Are DNA patents bad for medicine?
This paper considers the potential benefits and harms of DNA patenting for biomedical research and medical practice. It argues that, all things considered, the benefits of patenting DNA outweigh the harms, although societies should adopt policies designed to prevent or mitigate the harms associated with patenting. Some of these policies include: (1) reinforcing the research exemption for academic researchers, (2) raising the "bar" for the criteria of patentability, (3) restricting the scope of patents, (4) disclosing conflicts of interest related to DNA patents, (5) sharing the economic benefits of patenting with patients, and (6) providing insurance coverage for some types of genetic tests.
Resnik
David B
DB
2S-17 Brody Building, The Brody School of Medicine, East Carolina University, Greenville, NC 27858-4354, USA. resnikd@mail.ecu.edu
D035843:Biomedical Research; D001709:Biotechnology / Q000191:economics / Q000331:legislation & jurisprudence; D003132:Commerce / Q000191:economics / Q000941:ethics / Q000331:legislation & jurisprudence; D016265:Conflict of Interest; D004247:DNA; D036281:Genetic Research / Q000191:economics / Q000941:ethics / Q000331:legislation & jurisprudence*; D015894:Genome, Human; D006801:Humans; D007258:Informed Consent / Q000941:ethics / Q000331:legislation & jurisprudence; D010067:Ownership / Q000941:ethics / Q000331:legislation & jurisprudence; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D011369:Professional-Patient Relations / Q000941:ethics; D035521:Supreme Court Decisions; D014481:United States
D004247:DNA